Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

株式のランク #2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
株価
$17.34
時価総額
$9.98B
変化(1日)
-3.08%
変化(1年)
38.71%
国
IN
取引 Aurobindo Pharma Limited (AUROPHARMA)

カテゴリー

Healthcare
Aurobindo Pharma Limited(AUROPHARMA)の発行済株式数
June 2026 時点の発行済株式数 578.14M
Aurobindo Pharma Limited の最新の財務報告および株価によると、現在の発行済株式数は 578.14M です。March 2024 の終わりには、同社は 585.94M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Aurobindo Pharma Limited(AUROPHARMA)の発行済株式数の履歴(2004 ~ 2026)
各年末時点の発行済株式数
年 発行済株式数 変化
2026 (TTM) 578.14M -0.81%
2025 582.87M -0.52%
2024 585.94M 0.00%
2023 585.94M -0.01%
2022 586.00M 0.01%
2021 585.94M 0.00%
2020 585.94M 0.01%
2019 585.91M 0.00%
2018 585.88M 0.11%
2017 585.22M 0.16%
2016 584.27M 0.08%
2015 583.84M 0.00%
2014 583.84M 0.23%
2013 582.48M 0.04%
2012 582.24M 1.13%
2011 575.74M 6.32%
2010 541.53M 0.72%
2009 537.65M 0.24%
2008 536.39M 0.63%
2007 533.02M 1.56%
2006 524.84M 3.38%
2005 507.70M 6.06%
2004 478.69M 0.00%
類似企業や競合他社の発行済株式数